Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 11.

Yang, Jennie H. M., Khatri, Leena, Mickunas, Marius, Williams, Evangelia, Tatovic, Danijela, Alhadj Ali, Mohammad, Young, Philippa, Moyle, Penelope, Sahni, Vishal, Wang, Ryan, Kaur, Rejbinder, Tannahill, Gillian M., Beaton, Andrew R., Gerlag, Danielle M., Savage, Caroline O. S., Napolitano Rosen, Antonella, Waldron-Lynch, Frank, Dayan, Colin M. and Tree, Timothy I. M. 2019. Phenotypic analysis of human lymph nodes in subjects with new-onset type 1 diabetes and healthy individuals by flow cytometry. Frontiers in Immunology 10 , -. 10.3389/fimmu.2019.02547
file

Alhadj Ali, Mohammad, Liu, Yuk-Fun, Arif, Sefina, Tatovic, Danijela, Shariff, Hina, Gibson, Vivienne B., Yusuf, Norkhairin, Baptista, Roman, Eichmann, Martin, Petrov, Nedyalko, Heck, Susanne, Yang, Jennie H.M., Tree, Timothy I.M., Pujol-Autonell, Irma, Yeo, Lorraine, Baumard, Lucas R., Stenson, Rachel, Howell, Alex, Clark, Alison, Boult, Zoe, Powrie, Jake, Adams, Laura, Wong, Florence S., Luzio, Stephen, Dunseath, Gareth, Green, Kate, O'Keefe, Alison, Bayly, Graham, Thorogood, Natasha, Andrews, Robert, Leech, Nicola, Joseph, Frank, Nair, Sunil, Seal, Susan, Cheung, HoYee, Beam, Craig, Hills, Robert, Peakman, Mark and Dayan, Colin M. 2017. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes. Science Translational Medicine 9 (402) , eaaf7779. 10.1126/scitranslmed.aaf7779
file

Alhadj Ali, M., Gee, N.Tze, Howell, A., Stenson, R. and Dayan, C. 2017. Factors influencing effective recruitment to phase 1 interventional trials in new-onset type 1 diabetes: analysis of 12 months referrals to diabetes research centre [Abstract]. Diabetic Medicine 34 (S1) , P122. 10.1111/dme.16_13304

Alhadj Ali, M., Bowen-Morris, J., Gee, N. Tze, Stenson, R., Walkey, H., Littlemore, K. and Dayan, C. 2017. Use of a “YouTube” style video clip to raise interest amongst young people with new‐onset Type 1 diabetes in immunotherapy trials [Abstract]. Diabetic Medicine 34 (S1) , P315. 10.1111/dme.24_13304

Tatovic, Danijela, Luzio, Stephen, Dunseath, Gareth, Liu, Y., Alhadj Ali, Mohammad, Peakman, M. and Dayan, Colin Mark 2016. Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes. Diabetic Medicine 33 (11) , pp. 1564-1568. 10.1111/dme.13186
file

Alhadj Ali, M., Liu, Y., Howell, A., Eckhardt, L., Kyne, D., Green, K., Walkey, H., Peakman, M. and Dayan, C. 2016. Assessing fear of hypoglycaemia in newly disgnosed patients with Type 1 diabetes. Diabetic Medicine 33 (1) , P149. 10.1111/dme.20_13048

Alhadj Ali, Mohammad, Thrower, Sally L., Hanna, Stephanie J., Coulman, Sion A., Birchall, James C., Wong, F. Susan, Dayan, Colin Mark and Tatovic, Danijela 2015. Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin. Immunology 146 (3) , pp. 411-422. 10.1111/imm.12518
file

Alhadj Ali, Mohammad, Hanna, Stephanie, Wong, Susan and Dayan, Colin 2012. Functional modulation of epidermal dendritic cells by topical steroid treatment to optimise the tolerogenic potential of immunotherapy for type 1 diabetes. Presented at: 48th EASD Annual Meeting of the European Association for the Study of Diabetes 2012, Berlin, Germany, 1-5 October 2012. , vol. Supple. Springer Verlag, S192. 10.1007/s00125-012-2688-9

Alhadj Ali, Mohammad, Thrower, Sally, Harris, Stephanie, Wong, Susan and Dayan, Colin 2011. Optimizing the tolerogenic potential of a 'vaccine' for type 1 diabetes by topical betamethasone therapy. Presented at: 47th EASD Annual Meeting 2011, Lisbon, Portugal, 12-16 September 2011. , vol. Supple. Springer Verlag, S88-S89. 10.1007/s00125-011-2276-4

Alhadj Ali, Mohammad, Thrower, Sally, Harris, Stephanie, Wong, Susan and Dayan, Colin 2011. Effects of topical steroid and vitamin D therapy in optimizing the tolerogenic potential of a 'vaccine' for type 1 diabetes. Presented at: Diabetes UK Annual Professional Conference 2011, London, England, 30 March - 01 April 2011. , vol. S1. Wiley, p. 80. 10.1111/j.1464-5491.2011.03233_1.x

Alhadj Ali, Mohammad and Dayan, Colin M. 2009. Review: The importance of residual endogenous beta-cell preservation in type 1 diabetes. British Journal of Diabetes and Vascular Disease 9 (6) , pp. 248-253. 10.1177/1474651409351881

This list was generated on Sat Oct 24 04:01:02 2020 BST.